In the field of biomedical nanotechnology, chitosan and alginate —both naturally derived biopolymers — have garnered significant attention due to their ...

For years, the pharmaceutical market has relied on minoxidil and finasteride ... Their recent study tested the effectiveness ...

State Key Laboratory of Physical Chemistry of Solid Surface, Key Laboratory of Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

Despite its simplicity, cost-effectiveness and easy availability, visible spectrophotometric technique was never applied to the determination of VLGH in pharmaceuticals ... 10 mg lactose, 20 mg sodium ...

Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Hypopharyngeal Cancer. According to GlobalData, Phase II drugs for Hypopharyngeal Cancer does not ...

Department of Energy Chemistry and Materials Engineering, Shanxi Institute of Energy, Jinzhong, China A highly efficient and widely applicable adsorbent for the removal of methylene blue (MB) was ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...